Clinical Trials in Arizona

Showing 8721-8740 of 16,770 trials

Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma

NCT02128282

This study considers the safety and tolerability of increasing doses of CX-4945 in combination with gemcitabine plus cisplatin to determine the maximum tolerated dose (MTD) and the recommended Phase II dose (RP2D), followed by a randomized study that compares antitumor activity in cholangiocarcinoma patients receiving the standard of care gemcitabine plus cisplatin versus CX-4945 at the combination RP2D with gemcitabine plus cisplatin.

Cholangiocarcinoma

Senhwa Biosciences, Inc.127 participantsStarted Jun 2014

Scottsdale, Arizona, United States • Aurora, Colorado, United States • Jacksonville, Florida, United States +13 more locations

COMPLETED31 miles

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

NCT02026466

This is an observational registry, sponsored by Saint Luke's Hospital. This study is to be conducted according to DHHS Guidelines, applicable state regulations, and local IRB policies and procedures. The overall objective is to address current gaps in knowledge regarding CTO-PCI, as a prospective, multi-center, single-arm study of 1,000 participants.

Coronary Artery Disease

Saint Luke's Health System1,000 participantsStarted Dec 2013

Mesa, Arizona, United States • Phoenix, Arizona, United States • Torrance, California, United States +8 more locations

Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

Find Trials by Condition in Arizona

The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)

Effect of Efpeglenatide on Cardiovascular Outcomes

Convalescent Plasma in Outpatients With COVID-19

Triathlon Total Stabilizer (TS) Outcomes Study

A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain

Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome

The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate

Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ

A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Losartan for the Treatment of Pediatric NAFLD

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

Study of AMV564 in Subjects With Advanced Solid Tumors